8
Participants
Start Date
June 30, 2008
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
CC-10004
20 mg twice daily by mouth for 12 weeks, followed by a 4 week washout period and final assessment
New York University Tisch Hospital, New York
Collaborators (1)
Celgene Corporation
INDUSTRY
NYU Langone Health
OTHER